Search Results for: HNSCC


MEDI0457 (previously called INO-3112) is an investigational immunotherapy being developed to treat human papillomavirus (HPV)-positive cervical cancer and head and neck cancer. MEDI0457 was originally developed by Inovio, but MedImmune, ... Read more


JTX-2011 is a monoclonal antibody being developed by Jounce Therapeutics to treat solid tumors. It is intended to be used on its own or in combination with other cancer therapies. How JTX-2011 ... Read more